Icagen (Ligand Pharmaceuticals)

Icagen executed a targeted lead-generation strategy to identify and engage well-funded North American research foundations and academic laboratories with a high demand for early-stage discovery services. By focusing on institutions with significant research capabilities and funding, Icagen positioned its ion channel technology as a valuable tool for the initial phases of drug discovery. The initiative provided Icagen with a pipeline of high-potential leads, expanding their influence and driving growth opportunities by connecting with organizations at the forefront of early-stage drug discovery efforts.

CGT Market Reimbursement Negotiations Survey and Report


Biologics, RNA, and CGT Clinical Trial Landscape Assessment


Targeted Lead Generation for Medical Device Clinical Trials


Uncovering Post-Acquisition Synergies through a Site Assessment

Your Shortcut to Smarter Life-Sciences Decisions
Let’s discuss how Nice Insight’s market research and pricing intelligence can deliver actionable insights for your business.